Cargando…

Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation

Detalles Bibliográficos
Autores principales:	Schoots, Ivo G., Padhani, Anwar R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894174/ https://www.ncbi.nlm.nih.gov/pubmed/33089586 http://dx.doi.org/10.1111/bju.15277

Ejemplares similares

Diagnostic Performance of a Magnetic Resonance Imaging-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis
por: Hagens, Marinus J., et al.
Publicado: (2022)

Delivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosis
por: Schoots, Ivo G., et al.
Publicado: (2020)

Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
por: Schoots, Ivo G., et al.
Publicado: (2019)

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
por: Osses, Daniël F., et al.
Publicado: (2020)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Clinical implementation of pre‐biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer
por: Israël, Bas, et al.
Publicado: (2021)

Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications
por: Altay, Mehmet Sefa, et al.
Publicado: (2022)

Diagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy
por: Zhou, Yi, et al.
Publicado: (2018)

Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy
por: Park, Jung Jae, et al.
Publicado: (2022)

Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions
por: Schoots, Ivo G., et al.
Publicado: (2019)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging: Closer to Reality in a Subgroup of Prostate Cancer Patients?
por: Pomykala, Kelsey L., et al.
Publicado: (2022)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)

The meaning of sampling density in multiple repeat prostate biopsies
por: Hrbáček, Jan, et al.
Publicado: (2016)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
por: Porpiglia, Francesco, et al.
Publicado: (2015)

Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy
por: Truong, Matthew, et al.
Publicado: (2017)

Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?
por: Yu, Jiwoong, et al.
Publicado: (2021)

Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
por: Ryoo, Hyunsoo, et al.
Publicado: (2020)

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

An Magnetic Resonance Imaging–directed Targeted-plus-perilesional Biopsy Approach for Prostate Cancer Diagnosis: “Less Is More”
por: Hagens, Marinus J., et al.
Publicado: (2022)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
por: Kim, Jae Yeon, et al.
Publicado: (2023)

Is magnetic resonance/ultrasound fusion prostate biopsy better than systematic prostate biopsy? an updated meta- and trial sequential analysis
por: Wu, Jian, et al.
Publicado: (2015)

Magnetic Resonance Imaging-Guided Prostate Biopsy: Present and Future
por: Kim, Chan Kyo
Publicado: (2015)

The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy
por: Chang, Chao-Hsiang, et al.
Publicado: (2017)

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study
por: Lott, Felipe
Publicado: (2020)

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy
por: Wang, Fu-Bo, et al.
Publicado: (2017)

Can expressed prostatic secretions affect prostate biopsy decision of urologist?
por: Ergün, Osman, et al.
Publicado: (2019)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

Targeted prostate biopsy using magnetic resonance imaging-ultrasound fusion
por: Bockholt, Nathan, et al.
Publicado: (2015)

The urologist’s learning curve of “in-bore” magnetic resonance-guided prostate biopsy
por: Rosenzweig, Barak, et al.
Publicado: (2021)

Magnetic resonance imaging-guided prostate biopsy—A review of literature
por: Seetharam Bhat, Kulthe Ramesh, et al.
Publicado: (2021)

Transperineal Prostate Biopsy Targeted by Magnetic Resonance Imaging Cognitive Fusion
por: Drăgoescu, Petru Octavian, et al.
Publicado: (2023)

Editorial Comment: Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy
por: Ramacciotti, Lorenzo Storino, et al.
Publicado: (2023)

Malakoplakia of the Prostate as a Mimicker of Prostate Cancer on Prostate Health Index and Magnetic Resonance Imaging–Fusion Prostate Biopsy: A Case Report
por: Heah, Nathaniel H., et al.
Publicado: (2017)

The accuracy of prostate cancer diagnosis in biopsy-naive patients using combined magnetic resonance imaging and transrectal ultrasound fusion-targeted prostate biopsy
por: Uno, Hiromi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qshio0p32lmsunt934lfd4muk5